logo_big.png
Adynxx Announces Merger Agreement with Alliqua BioMedical and Provides Business and Clinical Update
22 avr. 2019 08h00 HE | Adynxx, Inc.
Adynxx announced plans to merge with Alliqua BioMedical and become a Nasdaq-listed public company in early 2019 Company announced receipt of substantial grant award from the National Institute on...
Alliqua, Inc. logo
Alliqua BioMedical Declares Contingent Special Dividend of $1.05 per Share and Announces Record Date for the Contingent Special Dividend and the Spin-Off of Contract Manufacturing Business
11 avr. 2019 16h49 HE | Alliqua BioMedical, Inc
LANGHORNE, Pa., April 11, 2019 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc. (Nasdaq: ALQA) announced today that its Board of Directors has declared a special cash dividend of $1.05 for each share of...
Alliqua, Inc. logo
Alliqua Biomedical CEO Provides Update to Shareholders
03 janv. 2019 07h00 HE | Alliqua BioMedical, Inc
LANGHORNE, Pa., Jan. 03, 2019 (GLOBE NEWSWIRE) -- To our Alliqua Shareholders: I hope you have seen our recent exciting announcements that we believe drove the increase in our market...
Alliqua, Inc. logo
Alliqua BioMedical to spin off and merge its Contract Manufacturing Business with TO Pharmaceuticals LLC to Create an Independent, Publicly Traded Company focused on Cannabinoid-Based Pharmaceutical Therapies
28 nov. 2018 07h30 HE | Alliqua BioMedical, Inc
LANGHORNE, Pa., Nov. 28, 2018 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc. (Nasdaq: ALQA) and TO Pharmaceuticals LLC, a privately held cannabinoid-based pharmaceutical therapy company (“TOP”), today...
Alliqua, Inc. logo
Alliqua BioMedical Inc. and Adynxx, Inc. Announce Merger Agreement to Create NASDAQ-listed Clinical-Stage Pharmaceutical Company with a Focus on Pain and Inflammation
12 oct. 2018 07h00 HE | Alliqua BioMedical, Inc
LANGHORNE, Pa. and SAN FRANCISCO, Oct. 12, 2018 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc. (Nasdaq:ALQA) and Adynxx, Inc., a privately held biopharmaceutical company, today announced that they...
Alliqua, Inc. logo
Alliqua BioMedical, Inc. Announces Closing Asset Sale to Celularity Inc.
07 mai 2018 16h15 HE | Alliqua BioMedical, Inc
Alliqua to return capital to shareholders Alliqua Retains H.C. Wainwright and Co. to evaluate strategic options LANGHORNE, Pa., May 07, 2018 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc....
ADYNXX_CLEAR.png
Alliqua BioMedical, Inc. Announces Definitive Asset Purchase Agreement with Celularity, Inc.
05 janv. 2018 16h30 HE | Alliqua BioMedical, Inc
YARDLEY, Pa., Jan. 05, 2018 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc. (NASDAQ:ALQA) (“Alliqua or the “Company”), a regenerative technologies company committed to restoring tissue and rebuilding...
ADYNXX_CLEAR.png
Alliqua BioMedical, Inc. Reports Third Quarter of Fiscal Year 2017 Financial Results and Increases Fiscal Year 2017 Financial Outlook
09 nov. 2017 07h02 HE | Alliqua BioMedical, Inc
YARDLEY, Pa., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"), a regenerative technologies company committed to restoring tissue and rebuilding...
ADYNXX_CLEAR.png
Alliqua BioMedical, Inc. Engages Cowen to Assist in Evaluating Potential Strategic Alternatives
09 nov. 2017 07h01 HE | Alliqua BioMedical, Inc
YARDLEY, Pa., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"), a regenerative technologies company committed to restoring tissue and rebuilding...
ADYNXX_CLEAR.png
Alliqua BioMedical, Inc. to Announce Third Quarter of Fiscal Year 2017 Results on November 9th
30 oct. 2017 16h05 HE | Alliqua BioMedical, Inc
YARDLEY, Pa., Oct. 30, 2017 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"), a regenerative medicine company committed to restoring tissue and rebuilding...